Ignite Creation Date:
2024-05-06 @ 6:42 PM
Last Modification Date:
2024-10-26 @ 2:53 PM
Study NCT ID:
NCT05751668
Status:
RECRUITING
Last Update Posted:
2024-05-23
First Post:
2023-02-21
Brief Title:
Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy Numbness or Weakness Due to Treatment With Paclitaxel Phase II
Sponsor:
Alliance for Clinical Trials in Oncology
Organization:
Alliance for Clinical Trials in Oncology
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2030-05-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-05-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-21
First Submit QC Date:
February 21 2023
Study First Post Date:
2023-03-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-01
Last Update Post Date:
2024-05-23
Last Update Post Date Type:
ACTUAL